(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem - 2Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
- 3Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 4Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?
- 5How much would you pay to meet a Real Housewife? At BravoCon, the limit does not exist.
- Artemis II crew take new photo of far side of the moon
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- Who is Artemis? Meet the Greek goddess who inspired NASA's return to the moon
- Feeling wonder every day improves our health. Here’s how to do it.
- Eight arrested in joint Scotland and Spain gang raids
- Lightning on Jupiter could be up to 1 million times stronger than on Earth
- What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- Step by step instructions to Shield Your Wellbeing Around 5G Pinnacles\
